CTO & VP of Engineering
Seno Medical
San Antonio, United States
At Seno Mr. Clingman has been involved from the early development of optoacoustic (photoacoustic) imaging through the current commercial offering (the Imagio). In this time, he contributed to the development of both hardware and software for the Imagio system including signal and image processing algorithm development and implementation, laser control software and firmware, electronics associated with the laser, integration with ultrasound systems, and the SenoGram AI tool.
Mr. Clingman worked on the Pre-Market Approval (PMA) FDA submission including providing characterization and clinical performance data, clinical study image management, and statistical support as part of that submission.
Additionally, Mr. Clingman has worked with the International Photoacoustic Standards Consortium (IPASC) to contribute to the development of standards for this emerging imaging technology.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
From concept to FDA approval: Entrepreneurs' stories of clinical device innovations
Tuesday, April 1, 2025
1:00pm – 2:30pm .
Meet a New Imaging Modality: Optoacoustics & Ultrasound for Breast Diagnosis
Tuesday, April 1, 2025
1:00pm – 1:30pm .